AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Hugen, PWH Burger, DM ter Hofstede, HJM Koopmans, PP Stek, M Hekster, YA Reiss, P Lange, JMA
Citation: Pwh. Hugen et al., Dose-finding study of a once-daily indinavir/ritonavir regimen, J ACQ IMM D, 25(3), 2000, pp. 236-245

Authors: Hugen, PWH Burger, DM ter Hofstede, HJM Koopmans, PP Hekster, YA
Citation: Pwh. Hugen et al., Development of an indinavir oral liquid for children, AM J HEAL S, 57(14), 2000, pp. 1332-1339

Authors: Hugen, PWH Burger, DM Brinkman, K ter Hofstede, HJM Schuurman, R Koopmans, PP Hekster, YA
Citation: Pwh. Hugen et al., Carbamazepine-indinavir interaction causes antiretroviral therapy failure, ANN PHARMAC, 34(4), 2000, pp. 465-470

Authors: ter Hofstede, HJM de Marie, D Foudraine, NA Danner, SA Brinkman, K
Citation: Hjm. Ter Hofstede et al., Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases, INT J STD A, 11(9), 2000, pp. 611-616

Authors: Hugen, PWH Burger, DM de Graaff, M ter Hofstede, HJM Hoetelmans, RMW Brinkman, K Meenhorst, PL Mulder, JW Koopmans, PP Hekster, YA
Citation: Pwh. Hugen et al., Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavir, THER DRUG M, 22(4), 2000, pp. 437-445

Authors: ter Hofstede, HJM van der Ven, AJAM Koopmans, PP
Citation: Hjm. Ter Hofstede et al., Drug reactions to cotrimoxazole in HIV infection: Possibly not due to the hydroxylamine metabolites of sulphamethoxazole, BR J CL PH, 47(5), 1999, pp. 571-573
Risultati: 1-6 |